An investigation by Democratic senators has raised concerns about conflicts of interest in telehealth companies' ties to ...

April 23 (UPI) --Eli Lilly Wednesday filed lawsuits against four telehealth companies alleging they are deceiving consumers by selling compounds of slightly-different versions of Lilly drugs ...

On Wednesday, pharmaceutical giant Eli Lilly sued four prominent telehealth companies that offer more affordable, off-brand versions of its patented best-selling GLP-1 medications Mounjaro and ...

While Ro doesn’t sell compounded tirzepatide, an online telehealth service called Hello Alpha advertises it for $249 a month and $449 a month for the same dosage levels as the Zepbound vials.

Eli Lilly will end its clinical trial of bamlanivimab in patients hospitalized with coronavirus disease 2019; pros and cons of telemedicine and in-person care; new guidance on opioid use in pregnancy.

Eli Lilly & Co. is suing four telehealth companies selling compounded versions of tirzepatide, the active ingredient in Lilly's weight-loss drug Zepbound and diabetes drug Mounjaro.

GREEN BAY, Wis. (WBAY) - A major drug company is announcing a new telehealth service. Drugmaker Eli Lilly is launching the service to connect people with health care providers remotely and deliver ...

Eli Lilly & Co. will only work with telehealth firms that agree to stop selling copycat versions of weight-loss drugs, diminishing the likelihood of a partnership with one most visible players in ...

Telehealth partners for Eli Lilly continue to sell compounded GLP-1 weight-loss drugs despite an agreement with the pharma giant to end copycat sales after the FDA ended a years-long shortage of ...

As Eli Lilly Wades Into Telehealth for Weight Loss, Doctors Are Wary The maker of Zepbound and Mounjaro launched a new platform to connect patients and prescribers. Listen to this article · 5:15 ...

Eli Lilly is suing four telemedicine companies selling compounded versions of its blockbuster obesity drug Zepbound and its diabetes treatment Mounjaro, escalating its battle against unauthorized ...

April 23 (UPI) --Eli Lilly Wednesday filed lawsuits against four telehealth companies alleging they are deceiving consumers by selling compounds of slightly-different versions of Lilly drugs ...